Tissue engineered vascular grafts: Origins, development, and current strategies for clinical application
详细信息 查看全文
- 作者：Ehsan Benrashid ehsan.benrashid@dm.duke.edu" class="auth_mail" title="E-mail the corresponding author ; Christopher C. McCoy christopher.mccoy@dm.duke.edu" class="auth_mail" title="E-mail the corresponding author ; Linda M. Youngwirth linda.youngwirth@dm.duke.edu" class="auth_mail" title="E-mail the corresponding author ; Jina Kim jina.kim1@dm.duke.edu" class="auth_mail" title="E-mail the corresponding author ; Roberto J. Manson roberto.manson@dm.duke.edu" class="auth_mail" title="E-mail the corresponding author ; James C. Otto jim.otto@dm.duke.edu" class="auth_mail" title="E-mail the corresponding author ; Jeffrey H. Lawson ; jeffrey.lawson@dm.duke.edu" class="auth_mail" title="E-mail the corresponding author
- 关键词：Bioengineering ; Blood vessel ; Tissue engineering ; Tissue engineered vascular graft ; Vascular graft ; Vascular conduit
- 刊名：Methods
- 出版年：2016
- 出版时间：15 April 2016
- 年：2016
- 卷：99
- 期：Complete
- 页码：13-19
- 全文大小：1225 K
文摘
- •
Clinical applications for tissue engineered vascular grafts (TEVG) include arterial bypass and hemodialysis access.
- •
TEVGs must be non-antigenic, durable, cost-effective, and remain patent to be feasible.
- •
Advances in cell culture, scaffolds, biomaterials, and manufacturing enhance TEVG feasibility.
- •
Newer technologies such as electrospinning and 3D-printing are available to manufacture TEVG.